Longevity Technology
@LongevityTech
Daily news and insights on research, investments and technologies that extend life and improve the quality of that extended life. #Longevity#
2.3K Following 19K Followers
Eight stories show where longevity is gaining momentum, from Alzheimer’s and Parkinson’s to biomarkers and glucose sensing.
Not every headline is a breakthrough, but each is worth checking. Read more at
#longevity# #geroscience# #biomarkers#
Show more
BPC-157 gets plenty of attention for healing and recovery, but promising animal research isn’t proof of human benefit.
An FDA evaluation found insufficient evidence of clinical safety information. Save this before believing the hype.
#longevity# #geroscience# #peptide#
Show more
Diagnostic Imaging Centers of Texas will pair MRI and CT with VoxNeuro’s FDA-cleared EEG software for people recovering from injuries.
#longevity# #MRI# #CT# #VoxNeuro# #EEG#
Show more
A Lancet Neurology study of 130 blood proteins in patients receiving lecanemab suggests amyloid clearance and cognitive response differ.
#longevity# #geroscience# #lecanemab# #amyloid# #bloodproteins#
Show more
Lovehoney’s hormone-free MenoPulse device launches, pairing air-pulse tech with early data on symptoms and autonomic function.
#longevity# #lovehoney# #menopulse# #symptoms# #autonomicfunction#
Show more
Mighty Therapeutics and the University of Washington will use pilot data on elamipretide to design a larger trial in older adults.
#longevity# #geroscience# #elamipretide# #trial# #olderadults#
Show more
Reservoir offers the chance to preserve today’s immune cells for potential future therapies – but what might those cells eventually be worth?
#longevity# #geroscience# #immunecells# #therapies# #reservoir#
Show more
Could GLP-1 drugs influence more than appetite? A 48-person trial found signals that semaglutide may affect alcohol consumption and cravings.
It’s early evidence, not an approved treatment. Read beyond the headline.
#longevity# #geroscience# #semaglutide#
Show more
Better U and Evernow have joined forces to pair menopause specialists with psychiatry in a nationwide telehealth service.
#longevity# #menopause# #psychiatry# #telehealth# #specialists#
Show more
QIMA Life Sciences launches SQINGEVITY, bringing biological testing and clinical studies together to examine claims about skin and hair aging.
#longevity# #geroscience# #sqingevity# #clinicalstudies# #aging#
Show more
Arvinas presented early biomarker data on ARV-102, an oral drug built to clear the LRRK2 protein, at a major Parkinson’s meeting.
#longevity# #geroscience# #arvinas# #arv102# #parkinsons#
Show more
Forecast for rapid growth by 2033, with disease-modifying therapies driving sales – and healthcare systems confronting the cost of access.
#longevity# #therapies# #healthcare# #access# #sales#
Show more
Small open-label study of ATR-258 saw fat loss, lean mass gains and better leg power, but no placebo group and just eight weeks long.
#longevity# #geroscience# #atr258# #fatloss# #leanmass#
Show more
GLP-1 receptor agonists and BPC-157 may share the peptide conversation, but their evidence is far from equal.
Before believing the hype, ask what was actually studied, in whom, and for how long. Which peptide claim should we examine next?
#longevity# #geroscience# #peptides#
Show more
Boehringer Ingelheim widens its kidney-disease partnership to cardiovascular targets, in a deal that could exceed $250 million.
#longevity# #boehringeringelheim# #kidneydisease# #cardiovascular# #partnership#
Show more
A two-year partnership with Ultrahuman aims to connect clinical biomarkers and wearable data, bringing aging assessment into public health.
#longevity# #geroscience# #ultrahuman# #biomarkers# #aging#
Show more
GPX4-targeting therapy reduces epigenetic age markers and circulating inflammation, raising questions about effects beyond treated skin.
#longevity# #geroscience# #GPX4# #epigeneticage# #inflammation#
Show more
Neither the FDA nor EMA recognizes aging as an indication – but the drafts, the precedent and the people on record are already in the room.
#longevity# #geroscience# #FDA# #EMA# #aging#
Show more
Oxford biotech secures $47 million to scale cell-based mRNA manufacturing, with an eye on therapies that require repeated dosing.
#longevity# #biotech# #mRNA# #manufacturing# #therapies#
Show more
A new partnership is combining a blood test, a cognitive app and national infrastructure to cut Britain’s years-long diagnosis wait.
#longevity# #bloodtest# #cognitive# #diagnosis# #Britain#
Show more
